JULY 2024LIFE SCIENCES REVIEW5CXO INSIGHTSCXO INSIGHTSHow Can We Tackle the Health Equity Gap to Innovative Medicines?Silvy Mardiguian,Senior Director, Head of HEOR, Europe & New Markets,BeiGene20Navigating Through Drug Discovery and DevelopmentStefano Biondi,Head of Pre-Clinical,Recordati S.p.A.22The value of new antibiotics in the fight against AMRPiero Rijli,Corporate Director, Regulatory Activities and Market Access, MENARINI Group24The Simple Things in Life Are Still the Best, Even in Clinical Development Ken Lee,General Manager and Region Head,Clinical Development, Asia Pacific,Syneos Health26Early Phase Biologics Characterization; a Key Factor for Risks Mitigation in Biologics Product DevelopmentsRafael Sande,Head Operations Characterization Large Molecule /Cell- and Gene Therapy Services,Solvias AG 28Microbiological Considerations for Achieving Drug Manufacturing ExcellenceJessica Wilson Rayser,Associate Director of Product Management, Accugenix, Charles River Laboratories18FEATURED COMPANYTOP 10SUPPLIERS IN EUROPE 2024Homeopathic ProductsPlantExtrakt 16Neli-Kinga Olah, Quality and Research Manager
< Page 4 | Page 6 >